How much does AML screening software cost?
AML screening software has no single sticker price; what a firm pays depends on the pricing model, the coverage it needs, the volume it screens, and how much of the review work stays with its own team. Most vendors price on one of three models: per-screen or per-check, per-seat or subscription, or coverage-based data licensing. The number on the contract is only part of the cost. False positives, integration effort, and the choice between software alone and software plus a managed service all feed into the real figure. This guide breaks down the cost drivers so a buyer can compare offers on total cost of ownership rather than headline price.
AML screening software is priced on the model the vendor chooses, not on a universal rate, so the same firm can receive very different quotes for functionally similar coverage. The honest way to compare is to separate the licence fee from everything that surrounds it: the labour to clear false positives, the effort to integrate, the coverage you actually need, and the cost of the matches a weaker system misses. A cheaper contract that generates more noise and leaves more work with your analysts can cost more in practice than a higher-priced system that resolves alerts precisely. This guide sets out the drivers so you can price on total cost of ownership.
How is AML screening software priced?
Vendors generally use one of three models. Per-screen or per-check pricing charges for each screening event, which is transparent at low volume but scales directly with activity, so a growing customer book or a busy payment corridor pushes the bill up in step with usage. Per-seat or subscription pricing charges by user or by tier, which suits case-management platforms where a defined team works the alerts, though it can decouple price from the value you draw if seats sit idle. Coverage-based data licensing charges for the watchlist and risk data you consume, such as sanctions, PEP and adverse-media coverage, priced by the breadth of regimes and depth of data rather than by transaction. Many vendors blend these, for example a platform subscription plus a data licence, which is why two quotes are rarely comparable line for line.
What drives the price?
Several factors move the number, and most of them are about your risk profile rather than the software itself. Coverage is the first: screening only a domestic sanctions list costs less than covering OFAC, the EU, the UK, Canada, Australia and APAC regimes plus trade restriction lists, but narrow coverage leaves exposure a global customer base cannot afford. Volume is the second, because per-check models scale with the number of screening events. Data depth is a third: tiered PEP and RCA data, adverse-media with source citations, and deep-tier ownership mapping cost more than a flat name list because they resolve entities rather than just match strings. Integration effort, the number of screening types (sanctions, PEP, adverse media, trade), the update cadence, and whether the system supports agentic entity resolution or leaves resolution to manual research all feed in as well.
| Pricing model | How you are charged | Where the cost concentrates |
|---|---|---|
| Per-screen / per-check | A fee for each screening event | Scales with customer growth and transaction volume; predictable per unit, less predictable in total |
| Per-seat / subscription | By user or by platform tier | Suited to case-management teams; cost can decouple from value if usage is uneven |
| Coverage-based data licence | By breadth of regimes and depth of data | Driven by how many lists and how deep the entity data you consume |
| Blended | Platform subscription plus a data licence | Common for unified platforms; makes quotes hard to compare line for line |
What is the hidden cost of false positives?
The largest cost in most screening programs is not the licence; it is the reviewer time spent clearing alerts that turn out to be nothing. The vast majority of alerts are false positives, and each one has to be read, investigated and dispositioned by an analyst before the system can move on. At scale that labour dominates the running cost, and a system that generates more noise quietly charges you in headcount even when its contract price looks low. This is why matching precision belongs in the cost conversation. Our screening engine is designed to reduce false positives by up to 80% through agentic entity resolution, so the same team clears more real risk in less time. The mechanics of why noise happens, and how to cut it, are set out in our guide to reducing false positives.
Is software-only cheaper than software plus a service?
Software alone usually carries a lower licence fee, but it is not automatically cheaper once you account for the work it leaves behind. A screening tool that returns alerts still needs a team to investigate them, tune the configuration, keep coverage current and document decisions for examiners. If you have that capacity, software-only can be efficient. If you do not, the gap is filled either by hiring or by a vendor's managed service, and the true comparison is between software plus your own labour and software plus a service, priced on the same total-of-ownership basis. Our platform is offered as a self-serve screening API for teams that run their own review, or as a unified case-management platform with human-in-the-loop automation for teams that want the workflow handled. The right choice depends on the review capacity you already have, not on the licence fee alone.
How do you compare total cost of ownership?
Add up four things, not one. First, the licence or data fee, on whichever model the vendor uses. Second, integration and onboarding effort, including engineering time to connect the screening API or platform to your systems. Third, the ongoing review labour, which is the reviewer hours consumed by the alert volume the system produces; a noisier system costs more here regardless of its contract price. Fourth, the cost of a missed match, meaning the regulatory and reputational exposure if the system under-detects. A cheap licence that generates heavy false-positive volume and still misses ownership-based exposure can cost far more than a higher-priced system that resolves entities precisely. Comparing vendors on total cost of ownership, rather than on the headline quote, is the only way to see which is genuinely cheaper. For a feature-by-feature vendor comparison to sit alongside this, see the best AML compliance software for fintechs.
What should you ask a vendor about price?
Ask questions that expose total cost, not just the quote. Which pricing model applies, and how does the bill move as our customer book and transaction volume grow? What coverage is included at this price, and what costs extra: which sanctions regimes, PEP tiers, adverse-media sources and trade lists? How is the data maintained and how often is it updated? What false-positive rate should we expect at our volume, and does the system apply entity resolution to reduce it, or leave resolution to our analysts? Is deep-tier ownership and the 50% Rule applied as part of screening, or a manual step? What integration effort is required, and what does onboarding involve? Is a managed-service option available, and how is it priced against software alone? Answers to these questions let you model the real running cost rather than react to a headline figure.
FAQ
How much does AML screening software cost?
There is no single price, because AML screening software is sold on different models and priced to the coverage and volume a firm needs. Vendors typically charge per-screen or per-check, per-seat or by subscription, or by coverage-based data licence, and many blend these, so two quotes are rarely comparable line for line. What moves the figure is your own risk profile: how many sanctions, PEP, adverse-media and trade regimes you cover, how many screening events you run, and how deep the entity data goes. The contract price is only part of the cost. Reviewer time spent clearing false positives, integration effort, and the exposure of a missed match all feed into what the program actually costs to run. The practical answer is to price on total cost of ownership rather than the headline quote, since a cheaper licence can carry heavier hidden costs at volume.
What is the most cost-effective AML screening pricing model?
No single model wins in every case; the most cost-effective one depends on how your activity behaves. Per-screen or per-check pricing is transparent and efficient at low or steady volume, but it scales directly with usage, so a fast-growing customer book or a busy payment corridor pushes the total up in step. Per-seat or subscription pricing suits case-management teams with a defined group of analysts, though cost can decouple from value if seats sit idle. Coverage-based data licensing fits firms that want to feed watchlist and risk data into an existing screening stack, priced by the breadth of regimes and depth of data rather than by transaction. The right choice follows your volume pattern, your team structure and whether you consume data or a full platform. Model each option against your projected growth before you commit, because a model that is cheap today can become the expensive one at scale.
Why do false positives affect the cost of screening?
False positives affect cost because clearing them consumes reviewer time, and at volume that labour often outweighs the software licence itself. The vast majority of alerts a screening system raises are not real matches, yet each one still has to be read, investigated and dispositioned by an analyst before the case can close. A system that generates more noise therefore charges you quietly in headcount, even when its contract price looks low, because your team spends its hours on alerts that resolve to nothing. This is why matching precision belongs in any honest cost comparison. Reducing false positives through entity resolution lets the same team clear more genuine risk in less time, which lowers the running cost without cutting coverage. When comparing vendors, weigh the expected false-positive rate at your volume alongside the licence fee, since the noisier option can be the more expensive one to operate.
Is a self-serve screening API cheaper than a full compliance platform?
A self-serve screening API usually carries a lower fee than a full case-management platform, but whether it is cheaper overall depends on the review capacity you already have. An API returns screening results that your own systems and analysts then act on, which is efficient if you have the team and workflow to handle investigation, tuning and documentation. A full platform bundles case management, audit-ready history and human-in-the-loop automation, so it costs more up front but absorbs work an API leaves with you. The real comparison is not API versus platform in isolation; it is API plus your own labour against platform on the same total-of-ownership basis. If you lack review capacity, the platform can be cheaper once the labour it saves is counted. Match the delivery option to the resources you have rather than choosing on licence fee alone, and model both against your actual alert volume.
What should I ask a vendor to compare AML screening cost fairly?
Ask questions that surface total cost rather than the headline quote. Start with the pricing model and how the bill moves as your customer book and transaction volume grow, since a model that is cheap now can become expensive at scale. Ask exactly what coverage is included and what costs extra: which sanctions regimes, PEP tiers, adverse-media sources and trade restriction lists, and how often the data is updated. Ask what false-positive rate to expect at your volume and whether the system applies entity resolution to reduce it, because that labour drives the running cost. Confirm whether deep-tier ownership and the 50% Rule are applied as part of screening or left as manual research. Finally, ask about integration effort and whether a managed-service option exists and how it is priced against software alone. Those answers let you model the real cost instead of reacting to a single figure.
Price it on total cost, not the quote.
Book a demo and we will walk through coverage, expected false-positive volume and delivery options, so you can compare on total cost of ownership rather than a headline figure. Self-serve API or unified case management, whichever fits your team.
Book a demo